Covered recipient · General Payments record
MATTHEW M BOWER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurocritical Care
General Payments · PY2024–2025
$417.22
- Reported across 15 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $387.82 | 13 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $111.44 | 1 |
| ABBVIE INC. | $40.87 | 2 |
| Averitas Pharma Inc. | $34.43 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.97 | 1 |
| Lundbeck LLC | $26.93 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.45 | 1 |
| Biogen, Inc. | $22.96 | 1 |
| Vanda Pharmaceuticals Inc. | $22.80 | 1 |
| UCB, Inc. | $21.21 | 1 |
| Neurocrine BioSciences, Inc. | $18.84 | 1 |
| Lilly USA, LLC | $15.33 | 1 |
| Teva Pharmaceuticals USA, Inc. | $13.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.87 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201548458 | CMS |
| ABBVIE INC. | $14.00 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201548460 | CMS |
| Averitas Pharma Inc. | $34.43 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248545431 | CMS |
| Biogen, Inc. | $22.96 | 09/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208442962 | CMS |
| GlaxoSmithKline, LLC. | $111.44 | 07/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190722168 | CMS |
| Lilly USA, LLC | $15.33 | 09/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186813463 | CMS |
| Lundbeck LLC | $26.93 | 08/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251777802 | CMS |
| Neurocrine BioSciences, Inc. | $18.84 | 05/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243030760 | CMS |
| Novartis Pharmaceuticals Corporation | $26.45 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200194796 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.97 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223930416 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.59 | 04/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247408590 | CMS |
| UCB, Inc. | $21.21 | 02/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224535201 | CMS |
| Vanda Pharmaceuticals Inc. | $22.80 | 12/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232951403 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.